<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="KYNLiV Inc. - Pioneering immunotherapeutic drug discovery for autoimmune diseases and cancer. Precision treatments that preserve immune function.">
    <title>KYNLiV Inc. - Immunotherapeutic Drug Discovery</title>
    <link rel="stylesheet" href="styles.css">
    <link rel="icon" type="image/x-icon" href="favicon.ico">
    <link href="https://fonts.googleapis.com/css2?family=Roboto:wght@300;400;700&display=swap" rel="stylesheet">
</head>
<body>
    <header id="header">
        <nav class="container">
            <ul>
                <li><a href="#home">Home</a></li>
                <li><a href="#about">About</a></li>
                <li><a href="#what-we-do">What We Do</a></li>
                <li><a href="#team">Team</a></li>
                <li><a href="#why">Why KYNLiV</a></li>
            </ul>
        </nav>
    </header>

    <main>
        <section id="home" class="hero parallax">
            <div class="hero-content">
                <h1 class="float-animation">KYNLiV Inc.</h1>
                <p>Immunotherapeutic Drug Discovery</p>
                <p><em>Kindness for Life</em></p>
            </div>
            <div class="scroll-indicator"></div>
        </section>

        <section id="about" class="section parallax">
            <div class="container">
                <h2>Welcome to KYNLiV</h2>
                <div class="card animate-left">
                    <p>At <strong>KYNLiV</strong>, we are revolutionizing the field of immunotherapy by developing cutting-edge treatments that target <strong>autoimmunity</strong> and <strong>cancer</strong> without compromising the immune system's natural defense mechanisms. Our therapies reprogram disease-associated immune cells to selectively suppress harmful responses, while <strong>preserving overall immune function</strong>. This innovative approach brings hope to millions suffering from immune-related disorders and cancers, offering a <strong>precise and organ-specific treatment</strong> that transforms the medical landscape.</p>
                </div>
            </div>
        </section>

        <section id="what-we-do" class="section parallax">
            <div class="container">
                <h2>What We Do</h2>
                <div class="card animate-right">
                    <p>Our focus is to pioneer <strong>immunotherapeutic treatments</strong> that restore balance to the immune system. We are driven by science and innovation, and we strive to develop therapies that:</p>
                    <ul>
                        <li><strong>Target specific autoimmune disorders</strong> and cancers linked to immune dysfunction.</li>
                        <li><strong>Preserve the body's natural defenses</strong>, avoiding the common issues of broad immunosuppression that lead to increased risk of infections or other health complications.</li>
                        <li><strong>Provide organ-specific immune regulation</strong>, offering patients more effective, targeted treatment options.</li>
                    </ul>
                    <p>We are committed to helping people with chronic immune-related diseases live healthier, fuller lives.</p>
                </div>
            </div>
        </section>

        <section id="team" class="section parallax">
            <div class="container">
                <h2>Meet Our Team</h2>
                <div class="team-grid">
                    <div class="team-member float-animation">
                        <h3>Cini Mathew John, PhD, RPh</h3>
                        <p>Director of Management and Research</p>
                    </div>
                    <div class="team-member float-animation">
                        <h3>Chinna Keshavsa Umeshappa, PhD</h3>
                        <p>Director of Scientific Discoveries</p>
                    </div>
                    <div class="team-member float-animation">
                        <h3>Fazlin Fauzi, MPharm, PhD</h3>
                        <p>Chief Scientist, Data and Informatics</p>
                    </div>
                    <div class="team-member float-animation">
                        <h3>Alice Joshua</h3>
                        <p>Strategic Partnership Advisor</p>
                    </div>
                    <div class="team-member float-animation">
                        <h3>Hanna Mathew</h3>
                        <p>Technology Officer</p>
                    </div>
                    <div class="team-member float-animation">
                        <h3>Annette John, MSc</h3>
                        <p>Intern Student</p>
                    </div>
                </div>
            </div>
        </section>

        <section id="why" class="section parallax">
            <div class="container">
                <h2>Why KYNLiV?</h2>
                <div class="card animate-left">
                    <p>Autoimmune diseases and cancers present some of the most <strong>complex challenges</strong> in modern medicine, where the immune system mistakenly attacks the body or fails to eliminate harmful cells. While medical advances have been made, there is <strong>no cure</strong> for many autoimmune diseases, and current treatments often rely on suppressing the immune system broadlyâ€”leading to severe side effects such as heightened risk of infections and even cancer.</p>
                    <p>At KYNLiV, we recognize the <strong>urgent need for more precise treatments</strong>, and our therapies aim to deliver the precision and effectiveness required to tackle these diseases at their core, <strong>without harmful side effects</strong>.</p>
                </div>
            </div>
        </section>
    </main>

    <footer>
        <div class="container">
            <p>&copy; <span id="current-year"></span> KYNLiV Inc. All rights reserved.</p>
        </div>
    </footer>

    <script src="script.js"></script>
</body>
</html>